- Home
- ODP vs XNCR Comparison
ODP vs XNCR Comparison
Compare ODP & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODP
- XNCR
- Stock Information
- Founded
- ODP 1986
- XNCR 1997
- Country
- ODP United States
- XNCR United States
- Employees
- ODP N/A
- XNCR N/A
- Industry
- ODP Other Specialty Stores
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ODP Consumer Discretionary
- XNCR Health Care
- Exchange
- ODP Nasdaq
- XNCR Nasdaq
- Market Cap
- ODP 611.3M
- XNCR 547.8M
- IPO Year
- ODP N/A
- XNCR 2013
- Fundamental
- Price
- ODP $27.75
- XNCR $12.40
- Analyst Decision
- ODP Hold
- XNCR Buy
- Analyst Count
- ODP 1
- XNCR 11
- Target Price
- ODP $19.00
- XNCR $22.20
- AVG Volume (30 Days)
- ODP 1.4M
- XNCR 1.2M
- Earning Date
- ODP 11-05-2025
- XNCR 11-05-2025
- Dividend Yield
- ODP N/A
- XNCR N/A
- EPS Growth
- ODP N/A
- XNCR N/A
- EPS
- ODP 0.84
- XNCR N/A
- Revenue
- ODP $6,690,000,000.00
- XNCR $146,929,000.00
- Revenue This Year
- ODP N/A
- XNCR $23.31
- Revenue Next Year
- ODP N/A
- XNCR N/A
- P/E Ratio
- ODP $33.09
- XNCR N/A
- Revenue Growth
- ODP N/A
- XNCR N/A
- 52 Week Low
- ODP $11.85
- XNCR $6.92
- 52 Week High
- ODP $32.21
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ODP 71.11
- XNCR 81.61
- Support Level
- ODP $27.65
- XNCR $11.36
- Resistance Level
- ODP $27.97
- XNCR $12.63
- Average True Range (ATR)
- ODP 0.22
- XNCR 0.54
- MACD
- ODP -0.01
- XNCR 0.10
- Stochastic Oscillator
- ODP 96.02
- XNCR 79.86
About ODP The ODP Corporation
The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue stems from the Veyer division.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.